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In everlasting memory of Eraldo Antonini: a brilliant
scientist, a charming and captivating man, a pioneer in
the field of blood biochemistry.
Since in the last few years clinicians and proteomicists
have rapidly reached the rendez-vous point, we are currently
in the middle of the docking manoeuvres. Two formerly-
independent worlds have started to cooperate, with the
declared intent to ameliorate the quality of the production
and handling processes of blood components and plasma
derivatives, with the shared goal to guarantee their safety and
effectiveness for the whole health care system.
This special issue tries to add some little pieces to this yet
complicated puzzle, since it represents an attempt to sail
across the mare magnum of the actual knowledge in this
research endeavour, to the end of summarizing the main
advancements. In the light of what emerges, blood-related
proteomics appears as much as promising as never before. In
particular, proteomics has been recently transformed from a1874-3919/$ – see front matter © 2009 Elsevier B.V. All rights reserved
doi:10.1016/j.jprot.2009.11.006mere basic-research expensive toy into a dramatically-sensi-
tive and high-throughput research tool which could be
exploited to investigate the molecular mechanisms of blood
and blood components and promises to establish quality
parameters in the blood-banking production-chain totally
anew.
The twenty eight accepted papers have been collected into
three subgroups:
1. Proteomics of Blood Banking;
2. Blood-related proteomics;
3. Blood Proteomics and the dynamic range.
An editorial by worldwide experts in the relative field
introduces each subgroup:
1. Hess J.R. and Grazzini G. for “Proteomics of Blood Banking”;
2. Tissot J.D. for the “Blood-related proteomics” section;
3. Righetti P.G. and Boschetti E. for “Blood Proteomics and the
dynamic range”.
This special issue, moreover, is the first attempt to bridge
the gap between independent laboratories and regroup recent
findings in the promising field of blood-related proteomics,
with the declared intent to regroup laboratories which have
lately branched out from the same research root. To this
regard it has been organized the firstmeeting in Viterbo (Italy),
on the 12th–14th October 2009, with the hope to organize a
second one in 2010 in some other location.
Although blood and blood components equally attract a
great deal of attention, actual concern still arises and persists
around the safety and effectiveness of long-stored labile blood
components, especially of red blood cell concentrates, in the
light of recent retrospective clinical observations. Therefore, a
whole section has been devoted to red blood cell storage and
proteomics. This section is introduced by the editorial co-
signed by Hess and Grazzini.
Blood storage has the potential to reduce the efficacy of
transfused components. What has been harder to show is that
these known changes have significant clinical pitfalls, as
stated by Hess in his article on red cell storage. The increasing
power of proteomics and metabolomics will allow a deeper
understanding of storage processes at a molecular level. This
offers the potential formore insightful physiologic and clinical
studies of the safety and efficacy of the present storage.
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the future.
Greening et al. reviewed how blood and its derivatives play
a critical role in worldwide health care systems, with blood
components having direct clinical indications. As the areas of
clinical validation of different disease states from blood-
derived sources (i.e., disease biomarkers) move towards
validation stages, the importance of controlled- and standard-
ized protocols is imperative.
Lion et al. from Tissot's group reviewed the current state of
knowledge about red blood cell storage lesions from a
proteomic and biochemical integrated perspective. He con-
cluded with suggesting a few possible proteomic studies that
would provide further knowledge of the molecular alterations
carried by RBCs stored in the cold for six weeks.
In parallel, Bosman et al. described red blood cell storage
lesions from a strict proteomic perspective and reported that
comparative proteomic analyses of erythrocytes and secreted
micro-vesicles support the theory that aging is accompanied
by increased binding of modified hemoglobins to band 3,
disruption of the band 3-mediated anchorage of the cytoskel-
eton to the lipid bilayer, vesicle formation, and antigenic
changes in band 3 conformation. This process involves
chaperones, stress proteins, and proteasomes.
Pasini, Mann, Lutz and Thomas provided an in-depth
portrait of red blood cell proteomics either under physiological
or pathological conditions through a double review article.
The authors reported that the high lipid content of the
environment in which membrane proteins are found often
causes a particular set of problems that must be overcome
when isolating the requiredmaterial before effective HPLC-MS
approaches can be performed. A full understanding of this
critical cell component will ultimately require, in addition to
proteomics, lipidomics, glycomics, interactomics and study of
post-translational modifications.
In the second part of their review, Pasini et al. provided a
short overview of some of themain achievements obtained by
comparative proteomics in the field of red blood cell-related
local and systemic diseases. The authors suggested some
additional areas of research to which comparative proteomic
approaches could be fruitfully applied or extended in combi-
nation with biochemical techniques to a better understanding
of disease mechanisms: from transfusion medicine to infec-
tious diseases, from cardiovascular affections to diabetes.
Turrini et al. summarized the wide range of hereditary
diseases affectingdifferent redcellmembrane functionsand the
membrane modifications induced by malaria parasite intracel-
lular growth. This represents a unique opportunity to study PTM
modifications in response of variable cellular stresses.
Goodman et al. profiled sickle RBCmembranes from of HU-
treated and untreated patients with the final aim to under-
stand hydroxyurea-induced changes at the proteomic level.
The proteins that significantly increased in abundance, such
as palmitoylated membrane protein 55 (p55), were mostly
membrane skeletal components involved in the regulation of
red blood cell shape and flexibility, and those showing a
significant decrease were components of the protein repair
and degradation machinery.
Sliipers et al. used a novel proteome-wide approach to
quantitatively analyze membrane proteins of healthy donorand patient erythrocytes in order to extend the current set of
diagnostic tools. Blue-native PAGE was used to detect protein
level changes in disordered erythrocyte membranes. They
could successfully confirm that erythrocyte spectrin levels
were dramatically decreased in hemolytic anemia-affected
patients.
Proteomic tools are also routinely applied for the study of
the storage issues related to other blood components, such as
platelets, as in the paper hereby presented by Schubert and
Devine. The authors focused on the application of proteomics
to identifymolecular mechanisms leading to the deterioration
of blood platelets during storage — a critical aspect in the
provision of platelet transfusion products. Once validated and
placed in a transfusion context, their data will provide further
understanding of the underlying molecular mechanisms
leading to platelet storage lesion.
Each section is aimed at providing an in-depth analysis of
the related topic, as it is for the Blood-related proteomics
section, which is opened by the editorial by Jean-Daniel Tissot.
In this section, the review of Liumbruno et al. provides a
panoramic view of the current papers available in literature
dealing with proteomics of blood components. Moreover, they
have given a glance at close prospective studies which
promise to shift the focus of proteomic attentions from the
end product to its provider, the donor, in a sort of Kantian
“Copernican revolution” in the field of transfusionmedicine. A
well-rounded portrait of the usefulness of proteomics in
blood-related research is accurately given, with references to
functional and applied prospective.
While a series of method and findings have been yet
produced and accumulated in the field of blood-related
proteomics, new technical innovations could pave the way
for further advancements. In this scenario, Urbani et al.
reported that although several MS-based bioinformatics
methods have been proposed for the elaboration of certain
MS data, the divergence of the findings by different research
groups on the same MS data suggests that the definition of a
reliable method has not yet been achieved. Thus, he proposed
an integrated software platform, MASCAP, intended for
comparative biomarker detection from MALDI- and SELDI-
TOF MS data. The analysis approach implemented in MASCAP
may simplify biomarker detection, by assisting the recognition
of proteomic expression signatures of the disease.
Basic science research is still a funding pillar of blood-
related proteomics, since we have not yet fully succeeded in
mapping the whole proteome of blood and its components. In
this special issue, Sintiprungrat et al. have provided some
insights into molecular mechanisms of biological processes
upon differentiation from monocytes to macrophages. Global
protein network analysis demonstrated that these altered
proteins were involved in cell death, lipid metabolism, cell
morphology, cellular movement, and protein folding.
McLeish et al. showed how a comprehensive understand-
ing of the regulation of neutrophil responses can be provided
by high-throughput proteomic technologies and sophisticated
computational analysis. The authors reviewed the application
of expression, structural and functional proteomic studies to
neutrophils.
D'Alessandro et al. summarized recent advancements in
the field of umbilical cord blood-derived hematopoietic
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routinely used as an alternative source of hematopoietic
stem cells, no substantial advances have been made in the
field of clinical regenerative medicine, due to the low cell/
dose limit within a single unit. A review is provided of the
proteomic studies that have investigated the plasticity of
cord blood-derived stem and progenitor cells, in particular
of CD34+ populations. Recent proteomic insights could pave
the way for the final understanding of the molecular
mechanisms regulating stem cell proliferation and differ-
entiation, thus broadening the application range for this
fruitful product.
Wasinger et al. used the MicroflowMF10 to partition CD34+
haematopoietic stem and progenitor cells and CD4+/CD8+ T-
cells in order to separate proteins restricted by cell number.
Less than 10 μg total protein per fraction was used for
comparative analysis, which revealed a series of differentially
expressed proteins between the 3 cell populations.
Proteomics in general and, in particular, MS could be
adopted to individuate early markers of certain haematologi-
cal and non-haematological diseases, such as cancers.
Vlasova et al. reviewed extensive data about the identity of
differential features detected on mass-spectra up to now in
order to draw conclusions about potency and perspectives of
MALDI-TOF mass-spectrometry for cancer biomarker search
in blood serum/plasma. This because of MALDI-TOF mass-
spectrometry, thanks to its high throughput and relative
simplicity, has become a popular tool for cancer research
during the last decade.
Gianazza et al. reported how it was possible to identify
markers for the early detection of Diabetic nephropathy (DN)
through proteomic analysis. Three peptides were found to be
differentially expressed in serum of patients as compared to
controls: the whole fibrinopeptide A peptide and two of its
fragments, respectively. The two fragments were under-
expressed in diabetic patients, while Fibrinopeptide A was
overexpressed, suggesting that anomalous turnover of
Fibrinopeptide A could be involved in the pathogenesis of
DN.
Thongboonkerd summarized important findings obtained
from recent proteomic studies applied to extracorporeal
blood purification and peritoneal dialysis in settings of
renal disease (ESRD) and acute kidney injury (AKI) and
hepatic failure. Efforts have been made to characterize the
toxins removed by diffusion (dialysis), convection (ultrafil-
tration), and/or adsorption (toxins are adsorbed onto the
dialysis membrane and are thus removed) using different
types of dialysis membrane.
Zamò and Cecconi reported how the application of
proteomics to the study of neoplastic haematological diseases
could help in the search for new diagnostic and prognostic
markers as well as in the development of new therapeutic
strategies. He focused on the results obtained in the field of
body fluid, cell lines, and tissues proteomics, and discussed
the improvement allowed by the newly developed proteomic
strategies, such as nanofluidic systems, analysis of formalin-
fixed tissues, and quantitative high-throughput techniques
(SILAC, ICAT, and iTRAQ).
The proteomic analysis of blood and blood components is
not an easy task. This is mainly due to the dynamic range ofcertain proteins, which often hinder detection of a whole
hidden proteome. In red blood cells for example, haemoglobin
accounts for approximately 90% of its dry weight, 98% of its
cytoplasmic protein content. A series of methods have been
recently accumulated and hereby reviewed by several authors
in order to deliver an exhaustive portrait, as it is introduced in
the brilliant editorial by Righetti and Boschetti.
Hortin examined the range of protein concentration for 18
proteins (secretory proteins or highly-expressed components
of specific tissues) measured over a year in a clinical
laboratory to provide data on pathophysiological extremes in
protein concentrations.
Di Girolamo et al. reported a systematic analysis on the
influence of pre-analytical factors [clotting times, temperature
and time storage, and addition of protease inhibitor (PI)] on
serum LMW proteome profiling. The use of standardized pre-
analytical and storage procedures together with an automated
peptide purification might minimize potential bias on serum
LMWprofiling results, thus allowing a better homogeneity and
reproducibility in futures proteomic studies.
Greening and Richard Simpson developed an enrichment
strategy for sub-proteome based on centrifugal ultrafiltration.
By using four commercially available filter membranes they
reported the identification of several proteins (e.g., rheuma-
toid factor D5, serine protease inhibitor A3N, and transmem-
brane adapter protein PAG) previously not reported in extant
HUPO Plasma Proteome Project datasets.
Levin et al. presented the coupling of label-free SAX
chromatography and IMAC to a data-independent nanoLC-
MS/MS (nanoLC-MSE) platform for analysis of blood plasma
and serum proteins. The combined approach provides com-
plementary information on sub-proteomes, potentially useful
for systems biology, biomarker discovery, and investigation of
post-translational modifications of blood proteins.
Ostroff et al. studied three sample collection variables
commonly encountered in archived sample sets: (1) three
different sample tube types, PPT plasma, SST serum, and Red
Top serum, (2) the time from venipuncture to centrifugation,
and (3) the time from centrifugation to freezing. Remarkably,
the results found no significant variation in the measure-
ments for most proteins (∼99%) when the two sample
processing times tested were 2 h or less, regardless of the
sample tube type.
Castagna et al. reviewed recent results obtainedwith SELDI-
TOF-MS as well as with other mass-spectrometry-based and
immunological methods. In particular, SELDI-TOF-MS being
optimal for low-molecular-weight biomarkers, has emerged as
a valid tool for hepcidin assay, a liver peptide hormone, that is
the central regulator of iron homeostasis.
Urbani et al. developed and validated a linear MALDI-TOF-
MS protein profiling method to explore the low protein
molecular weight region (5–20 kDa) of serum samples. His
data showed critical conditions for serum protein profiles
depending on storage times and temperatures: Apolipoprotein
A-IV and complement C3 protein fragment, transthyretin and
the oxidized isoforms in different apolipoprotein species
represent the major molecular features of such a degradation
pattern.
Josic et al. by using anion-exchange chromatography and
affinity chromatographywith immobilized heparin, fractionated
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other non-binding proteins fromF IX. Thismethodology resulted
very helpful for further process optimization, rapid identification
of target proteins with relatively low abundance, and for the
design of subsequent steps for their removal or purification.
While seemingly representing only one of the numerous
attempts to start a network of information among multiple
laboratoriesworkingonthisdelicate topic, thisBloodProteomics
issue promises to start bridging the persisting gaps between the
clinical and the academic milieu. For the foreseeable future,
when a full collaboration between these two endeavours will be
accomplished, proteomics will perhaps find a widespread diffu-
sion in the clinical routine as well, in order to deliver blood
components and plasma derivatives which are safe, efficient
and effective for the whole health care system.
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